Skip to main content

Psoriatic Arthritis

Patient-Reported Nausea and Fatigue Related to Methotrexate: A Prospective, Self-Controlled Study in the ArthritisPower Registry

This study aims to quantify methotrexate (MTX)-associated side effects in rheumatoid arthritis (RA) or psoriatic arthritis (PsA) patients. In the ArthritisPower app and registry, a self-controlled case series study design with electronic patient-reported outcome measures (e-PROMs) was used.

Read More

Patient Perspectives on the Pathway to Psoriatic Arthritis Diagnosis: Results from a Web-Based Survey of Patients in the United States

BMC Logo

There is limited information available about the diagnostic experience of patients with psoriatic arthritis (PsA). 203 participants were interviewed and surveyed about their diagnostic journey with PsA. Participants reported delays in diagnosis and misdiagnoses and reported joint pain and stiffness as symptoms that led them to seek medical care. Participants with joint pain, swollen joints, and sausage-like fingers or toes were more likely to have a shorter time to diagnosis whereas fatigue, foot problems, stiffness, and back pain symptoms reported by participants led to longer diagnosis times.

Read More

Contraception methods used by women with rheumatoid arthritis and psoriatic arthritis

In Clinical Rheumatology, Leverenz et al. report a study in which they investigated contraceptive methods used in young women with Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA) and correlated the efficacy of the contraceptive methods with the use of concomitant rheumatic medications. Of the 164 women included, women with RA and PsA reported similar utilization of highly effective contraception methods and effective methods, but different utilization of ineffective methods and no methods. These proportions remained similar across subgroups taking methotrexate, anti-TNF biologics, and novel medications. Women with PsA were more likely to report no methods of contraception.

Read More